ArticleBMC cell biology2018
Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma.
Josip Skoko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it